Systematic proteome-wide Mendelian randomization to prioritize causal plasma proteins for skin cancers.

Commun Biol

Department of Computational Diagnostic Radiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan.

Published: December 2024

Skin cancer is one of the most common cancers worldwide. Some risk factors including sun exposure and MC1R variants are recognized; however, the identification of additional genetic factors is essential for the development of novel therapeutic strategies. Here, we conducted a proteome-wide Mendelian randomization (MR) using plasma protein quantitative trait loci (pQTLs) from a published study and the UK Biobank genome-wide association study (GWAS) of skin cancers. We replicated the published result of ASIP, which was significantly associated with increased risks of basal cell carcinoma (BCC) and malignant melanoma. Moreover, we newly identified CTSS, which was significantly associated with a decreased risk of BCC. A series of replication analyses using the DeCODE pQTLs and the FinnGen GWAS, and sensitivity analyses including Steiger filtering, reverse MR, and Bayesian colocalization, supported our primary results. Our findings highlighted the possibility of prioritizing proteins for novel therapeutic or preventive targets and biomarkers for skin cancers.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s42003-024-07403-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11659389PMC

Publication Analysis

Top Keywords

skin cancers
12
proteome-wide mendelian
8
mendelian randomization
8
novel therapeutic
8
systematic proteome-wide
4
randomization prioritize
4
prioritize causal
4
causal plasma
4
plasma proteins
4
skin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!